More meticulously following treat-to-target in RA does not lead to less radiographic progression: A longitudinal analysis in BIODAM

Sofia Ramiro; Robert Landewé; Désirée van der Heijde; Alexandre Sepriano; Oliver FitzGerald; Mikkel Østergaard; Joanne Homik; Ori Elkayam; J Carter Thorne; Maggie J Larché; Gianfranco Ferraccioli; Marina Backhaus; Gilles Boire; Bernard Combe; Thierry Schaeverbeke; Alain Saraux; Maxime Dougados; Maurizio Rossini; Marcello Govoni; Luigi Sinigaglia; Alain G Cantagrel; Cornelia F Allaart; Cheryl Barnabe; Clifton O Bingham; Dirkjan van Schaardenburg; Hilde B Hammer; Rana Dadashova; Edna Hutchings; Joel Paschke; Walter P Maksymowych

More meticulously following treat-to-target in RA does not lead to less radiographic progression: A longitudinal analysis in BIODAM

Sofia Ramiro^*, Robert Landewé, Désirée van der Heijde, Alexandre Sepriano, Oliver FitzGerald, Mikkel Østergaard, Joanne Homik, Ori Elkayam, J Carter Thorne, Maggie J Larché, Gianfranco Ferraccioli, Marina Backhaus, Gilles Boire, Bernard Combe, Thierry Schaeverbeke, Alain Saraux, Maxime Dougados, Maurizio Rossini, Marcello Govoni, Luigi SinigagliaAlain G Cantagrel, Cornelia F Allaart, Cheryl Barnabe, Clifton O Bingham, Dirkjan van Schaardenburg, Hilde B Hammer, Rana Dadashova, Edna Hutchings, Joel Paschke, Walter P Maksymowych

^*Corresponding author for this work

Department for Rheumatology and Spine Diseases

Abstract

Background:

A Treat-to-Target approach (T2T) is broadly considered to lead to better clinical outcomes and recommended in patients with RA. However, very few studies have analyzed the effect of T2T on radiographic progression, and any such studies have provided inconsistent results.

Original language	English
Publication date	2022
Publication status	Published - 2022
Event	EULAR 2022 - Copenhagen Duration: 1 Jun 2022 → 4 Jun 2022

Conference

Conference	EULAR 2022
City	Copenhagen
Period	01/06/2022 → 04/06/2022

Keywords

Antirheumatic Agents/therapeutic use
Arthritis, Rheumatoid/diagnostic imaging
Disease Progression
Female
Humans
Male
Middle Aged
Remission Induction
Severity of Illness Index
treat-to-target
radiographic progression
RA
outcomes

Cite this

Ramiro, S., Landewé, R., van der Heijde, D., Sepriano, A., FitzGerald, O., Østergaard, M., Homik, J., Elkayam, O., Thorne, J. C., Larché, M. J., Ferraccioli, G., Backhaus, M., Boire, G., Combe, B., Schaeverbeke, T., Saraux, A., Dougados, M., Rossini, M., Govoni, M., ... Maksymowych, W. P. (2022). More meticulously following treat-to-target in RA does not lead to less radiographic progression: A longitudinal analysis in BIODAM. . Annals of the Rheumatic Diseases 81 Suppl 1: 279. Abstract from EULAR 2022, Copenhagen.

More meticulously following treat-to-target in RA does not lead to less radiographic progression: A longitudinal analysis in BIODAM. / Ramiro, Sofia; Landewé, Robert; van der Heijde, Désirée et al.
2022. . Annals of the Rheumatic Diseases 81 Suppl 1: 279 Abstract from EULAR 2022, Copenhagen.

Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

Ramiro, S, Landewé, R, van der Heijde, D, Sepriano, A, FitzGerald, O, Østergaard, M, Homik, J, Elkayam, O, Thorne, JC, Larché, MJ, Ferraccioli, G, Backhaus, M, Boire, G, Combe, B, Schaeverbeke, T, Saraux, A, Dougados, M, Rossini, M, Govoni, M, Sinigaglia, L, Cantagrel, AG, Allaart, CF, Barnabe, C, Bingham, CO, van Schaardenburg, D, Hammer, HB, Dadashova, R, Hutchings, E, Paschke, J & Maksymowych, WP 2022, 'More meticulously following treat-to-target in RA does not lead to less radiographic progression: A longitudinal analysis in BIODAM', EULAR 2022, Copenhagen, 01/06/2022 - 04/06/2022 pp. . Annals of the Rheumatic Diseases 81 Suppl 1: 279.

@conference{9a25bb74e59840f288b4e96af4db9e03,

title = "More meticulously following treat-to-target in RA does not lead to less radiographic progression: A longitudinal analysis in BIODAM",

abstract = "Background:A Treat-to-Target approach (T2T) is broadly considered to lead to better clinical outcomes and recommended in patients with RA. However, very few studies have analyzed the effect of T2T on radiographic progression, and any such studies have provided inconsistent results.",

keywords = "Antirheumatic Agents/therapeutic use, Arthritis, Rheumatoid/diagnostic imaging, Disease Progression, Female, Humans, Male, Middle Aged, Remission Induction, Severity of Illness Index, treat-to-target, radiographic progression, RA, outcomes",

author = "Sofia Ramiro and Robert Landew{\'e} and \{van der Heijde\}, D{\'e}sir{\'e}e and Alexandre Sepriano and Oliver FitzGerald and Mikkel {\O}stergaard and Joanne Homik and Ori Elkayam and Thorne, \{J Carter\} and Larch{\'e}, \{Maggie J\} and Gianfranco Ferraccioli and Marina Backhaus and Gilles Boire and Bernard Combe and Thierry Schaeverbeke and Alain Saraux and Maxime Dougados and Maurizio Rossini and Marcello Govoni and Luigi Sinigaglia and Cantagrel, \{Alain G\} and Allaart, \{Cornelia F\} and Cheryl Barnabe and Bingham, \{Clifton O\} and \{van Schaardenburg\}, Dirkjan and Hammer, \{Hilde B\} and Rana Dadashova and Edna Hutchings and Joel Paschke and Maksymowych, \{Walter P\}",

note = "COPECARE; EULAR 2022 ; Conference date: 01-06-2022 Through 04-06-2022",

year = "2022",

language = "English",

pages = ". Annals of the Rheumatic Diseases 81 Suppl 1: 279",

}

TY - ABST

T1 - More meticulously following treat-to-target in RA does not lead to less radiographic progression: A longitudinal analysis in BIODAM

AU - Ramiro, Sofia

AU - Landewé, Robert

AU - van der Heijde, Désirée

AU - Sepriano, Alexandre

AU - FitzGerald, Oliver

AU - Østergaard, Mikkel

AU - Homik, Joanne

AU - Elkayam, Ori

AU - Thorne, J Carter

AU - Larché, Maggie J

AU - Ferraccioli, Gianfranco

AU - Backhaus, Marina

AU - Boire, Gilles

AU - Combe, Bernard

AU - Schaeverbeke, Thierry

AU - Saraux, Alain

AU - Dougados, Maxime

AU - Rossini, Maurizio

AU - Govoni, Marcello

AU - Sinigaglia, Luigi

AU - Cantagrel, Alain G

AU - Allaart, Cornelia F

AU - Barnabe, Cheryl

AU - Bingham, Clifton O

AU - van Schaardenburg, Dirkjan

AU - Hammer, Hilde B

AU - Dadashova, Rana

AU - Hutchings, Edna

AU - Paschke, Joel

AU - Maksymowych, Walter P

N1 - COPECARE

PY - 2022

Y1 - 2022

N2 - Background:A Treat-to-Target approach (T2T) is broadly considered to lead to better clinical outcomes and recommended in patients with RA. However, very few studies have analyzed the effect of T2T on radiographic progression, and any such studies have provided inconsistent results.

AB - Background:A Treat-to-Target approach (T2T) is broadly considered to lead to better clinical outcomes and recommended in patients with RA. However, very few studies have analyzed the effect of T2T on radiographic progression, and any such studies have provided inconsistent results.

KW - Antirheumatic Agents/therapeutic use

KW - Arthritis, Rheumatoid/diagnostic imaging

KW - Disease Progression

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Remission Induction

KW - Severity of Illness Index

KW - treat-to-target

KW - radiographic progression

KW - RA

KW - outcomes

M3 - Conference abstract for conference

SP - . Annals of the Rheumatic Diseases 81 Suppl 1: 279

T2 - EULAR 2022

Y2 - 1 June 2022 through 4 June 2022

ER -

More meticulously following treat-to-target in RA does not lead to less radiographic progression: A longitudinal analysis in BIODAM

Abstract

Conference

Keywords

Fingerprint

Cite this